NO20076515L - Hydantoinforbindelser - Google Patents

Hydantoinforbindelser

Info

Publication number
NO20076515L
NO20076515L NO20076515A NO20076515A NO20076515L NO 20076515 L NO20076515 L NO 20076515L NO 20076515 A NO20076515 A NO 20076515A NO 20076515 A NO20076515 A NO 20076515A NO 20076515 L NO20076515 L NO 20076515L
Authority
NO
Norway
Prior art keywords
hydantoin
treating
useful
formula
relates
Prior art date
Application number
NO20076515A
Other languages
English (en)
Inventor
Mark Spyvee
Shawn Schiller
Eric Carlson
Qian Chen
Heather Davis
Jr Brian M Gallagher
Christina Shaffer
Nancy Wong
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO20076515L publication Critical patent/NO20076515L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører anvendelse av hydantoinforbindelser i følge formel I som er nyttige for å behandle eller forhindre autoimmune forstyrrelser. Foreliggende oppfinnelse tilveiebringer også sammensetninger og anvendelser derav. (I)
NO20076515A 2005-05-27 2007-12-19 Hydantoinforbindelser NO20076515L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68559405P 2005-05-27 2005-05-27
PCT/US2006/020848 WO2006128143A2 (en) 2005-05-27 2006-05-26 Hydantoin compounds

Publications (1)

Publication Number Publication Date
NO20076515L true NO20076515L (no) 2007-12-19

Family

ID=37189015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076515A NO20076515L (no) 2005-05-27 2007-12-19 Hydantoinforbindelser

Country Status (15)

Country Link
US (2) US7666875B2 (no)
EP (2) EP1888583A2 (no)
JP (1) JP2008542304A (no)
KR (1) KR20080013931A (no)
CN (1) CN101263141A (no)
AU (1) AU2006251947A1 (no)
BR (1) BRPI0609895A2 (no)
CA (1) CA2609270A1 (no)
DE (1) DE06771541T1 (no)
IL (1) IL187279A0 (no)
MX (1) MX2007014888A (no)
NO (1) NO20076515L (no)
RU (1) RU2007149327A (no)
TW (1) TW200724140A (no)
WO (1) WO2006128143A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
WO2007139813A1 (en) * 2006-05-26 2007-12-06 Eisai R&D Management Co., Ltd Imidazoazephinone compounds
WO2007139948A2 (en) * 2006-05-26 2007-12-06 Eisai R & D Management Co., Ltd Imidazoazepinone compounds
US7985746B2 (en) 2006-05-26 2011-07-26 Eisai R&D Management Co., Ltd. Imidazoazepinone compounds
AU2007293416A1 (en) * 2006-09-07 2008-03-13 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
KR20100088695A (ko) * 2007-11-15 2010-08-10 에자이 알앤드디 매니지먼트 가부시키가이샤 거울상 이성질체가 강화된 이미다조아제피논 화합물
WO2009064431A1 (en) * 2007-11-15 2009-05-22 Eisai E & D Management Co., Ltd. Methods of use
JP2011504878A (ja) * 2007-11-26 2011-02-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物の製造方法
BR112017003658B1 (pt) 2014-08-28 2022-12-06 Asceneuron Sa Composto, mistura, método para inibição de uma glicosidase, e, composição farmacêutica
EP3419976B1 (en) 2016-02-25 2021-04-07 Asceneuron SA Acid addition salts of piperazine derivatives
US11612599B2 (en) 2016-02-25 2023-03-28 Asceneuron Sa Glycosidase inhibitors
EP3585783A2 (en) 2016-02-25 2020-01-01 Asceneuron SA Sulfoximine glycosidase inhibitors
US11731972B2 (en) * 2018-08-22 2023-08-22 Asceneuron Sa Spiro compounds as glycosidase inhibitors
WO2020039028A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Tetrahydro-benzoazepine glycosidase inhibitors
EP3841093B1 (en) 2018-08-22 2023-06-21 Asceneuron SA Succinate and fumarate acid addition salts of piperazine derivatives useful as glycosidase inhibitors
US12016852B2 (en) 2018-08-22 2024-06-25 Asceneuron Sa Pyrrolidine glycosidase inhibitors
WO2024092040A1 (en) * 2022-10-26 2024-05-02 Protego Biopharma, Inc. Spirocycle containing bicyclic heteroaryl compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US685594A (en) 1901-04-19 1901-10-29 Frank A Franklin Pulp-washing machine.
JP4710606B2 (ja) * 2003-04-18 2011-06-29 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
EP1786816A4 (en) * 2003-09-10 2009-11-04 Virochem Pharma Inc SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds

Also Published As

Publication number Publication date
AU2006251947A1 (en) 2006-11-30
US20060270696A1 (en) 2006-11-30
WO2006128143A2 (en) 2006-11-30
MX2007014888A (es) 2008-02-19
CA2609270A1 (en) 2006-11-30
RU2007149327A (ru) 2009-07-10
US20100113446A1 (en) 2010-05-06
EP1888583A2 (en) 2008-02-20
EP2336131A1 (en) 2011-06-22
WO2006128143A3 (en) 2007-03-29
CN101263141A (zh) 2008-09-10
BRPI0609895A2 (pt) 2011-10-11
KR20080013931A (ko) 2008-02-13
TW200724140A (en) 2007-07-01
IL187279A0 (en) 2008-02-09
JP2008542304A (ja) 2008-11-27
US7666875B2 (en) 2010-02-23
DE06771541T1 (de) 2008-09-11

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20081421L (no) Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
EA201070238A1 (ru) Соединения пиримидина
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
EA200870292A1 (ru) Соединения на основе имидазола, композиции, содержащие их, и способы их применения
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
TW200714604A (en) Substituted heterocycles and the uses thereof
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20074941L (no) Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
DK2358717T3 (da) Aminotetrahydropyraner som dipeptidylpeptidase-iv-inhibitorer tilbehandling eller forebyggelse af diabetes
NO20063449L (no) Substituerte heterocykler og deres anvendelse
WO2007070434A3 (en) Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
SE0403006D0 (sv) New compounds
EA201000550A1 (ru) Производные тиазола
ATE537170T1 (de) Cgrp-rezeptorantagonisten
NO20071378L (no) Tiazolo-naftylsyrer.
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application